Diabetes Stem Cell Treatment in India

✍️ Written By:Nishat Arfin
|🩺 Reviewed By:Tabish Iqbal
|
Published: October 14, 2021 | Updated: June 16, 2026

Advanced Diabetes Care in India

Stem Cell Therapy for Diabetes in India | Advanced Regenerative Treatment

Viezec provides advanced stem cell therapy programs for diabetes patients in India. Our regenerative medicine approach focuses on personalized treatment planning, international patient support, and comprehensive medical assistance to help improve quality of life and long-term health outcomes.

10,000+
Patients Treated
85%
Improvement Rate
16+ Years
Experience
50+
Conditions Covered
50+ Countries
Global Patients
★★★★★
Google Reviews


Diabetes & Regenerative Medicine

Can Stem Cell Therapy Help Improve
Blood Sugar Control in Diabetes?

Researchers continue to investigate stem cells for their potential to support beta cell regeneration and modulate immune activity relevant to diabetes management. Studies have explored both autoimmune and metabolic mechanisms that may influence glucose regulation.

Evidence is still evolving, and outcomes may vary depending on the type of diabetes, disease progression, and individual patient factors. Comprehensive endocrinological evaluation and eligibility assessment are essential before considering this investigational therapeutic approach.

Current Areas of Research

  • Potential support for beta cell regeneration
  • Investigation of immune system modulation
  • Research into glucose regulation mechanisms
  • Studies evaluating safety and clinical outcomes
Important:
Stem cell therapy for diabetes remains investigational and should only be considered after consultation with qualified endocrinology and regenerative medicine professionals.

Key Takeaways

  • 01. Therapy overview:
    The treatment uses umbilical cord–derived mesenchymal stem cells (WJ-MSCs) to aid pancreas repair, enhance insulin production, and help lower glucose levels.
  • 02. Implementation details:
    The procedure includes donor stem cell extraction, HLA matching, and cGMP-compliant lab processing. Cells are infused through methods such as intravenous, intramuscular, intrathecal, intra-arterial, or subcutaneous routes.
  • 03. Reported outcomes:
    Among 122 diabetes patients (53 type 1, 78 type 2), around 32% of type 1 and 50% of type 2 patients experienced improved glucose stability. About 38 patients reported reduced medication use — roughly 60% in type 2 and 29% in type 1 cases.
  • 04. Important caution:
    The therapy remains experimental with individual-specific outcomes. It is not a guaranteed cure, and no fetal or embryonic stem cells are used.
🛡️

Ethical & Transparent Patient Guidance

We provide consultation, case evaluation, and patient support services in regenerative medicine.
As per Indian guidelines, stem cell-based interventions (beyond approved uses) are
investigational and available only within regulated clinical research settings.
We also assist patients in accessing internationally accredited treatment pathways.


Talk to Our Experts →

Our Testimonials

Related Videos

Recent Blog Posts

Patients Rating

4.8 average based on 654 reviews.


5 star
392
4 star
176
3 star
49
2 star
30
1 star
7

Upload your reports today for a free online consultation

Upload Reports






    Menu